GSK3B and head and neck squamous cell carcinoma: The restoration of proliferation and sphere formation ability of shLIMP-2 cells treated with CHIR demonstrated that GSK3β is required for LIMP-2-mediated malignant phenotype of HNSCC (Figs. 7e–g and S9d).